PerkinElmer
check quantity

VIEWPLATE-1536, White, clear bottom, untreated, Case of 60

1536-well untreated ViewPlate with white well walls and a clear bottom for viewing plates under a microscope or bottom reading measurements.

Part Number
List Price
Your Price
Quantity
6004490
1928.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Introducing PerkinElmer's ViewPlate Microplates engineered for bottom reading systems. This high quality microplate can be utilized in your cell based assay for superior results.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

Specifications

Automation Compatible Yes
Coating Treatment Untreated
Color White/Clear Bottom
Detection Method Luminescence, Alpha, Time-Resolved Fluorescence (TRF & TR-FRET), Radiometric
Material Polystyrene
Product Brand Name ViewPlate
Shipping Condition Ambient
Sterile No
Unit Size Case of 60
Wells Number 1536 well plate
Resources, Events & More
  • All

Brochure

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.

PDF 4 MB